CLINICAL_TRIALS
trial_result
· 2024-03-22
Clinical Trial Update: Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. [Phase 2]
Summary
Phase 2 trial update on erenumab-aooe for trigeminal neuropathic pain (terminated; results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Trigeminal Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2024-03-22